0001104659-23-026139.txt : 20230227 0001104659-23-026139.hdr.sgml : 20230227 20230227180834 ACCESSION NUMBER: 0001104659-23-026139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230224 FILED AS OF DATE: 20230227 DATE AS OF CHANGE: 20230227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Appelhans Dannielle CENTRAL INDEX KEY: 0001874962 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38586 FILM NUMBER: 23677155 MAIL ADDRESS: STREET 1: C/O RUBIUS THERAPEUTICS, INC. STREET 2: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rubius Therapeutics, Inc. CENTRAL INDEX KEY: 0001709401 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042688109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O VERDOLINO & LOWEY, P.C. STREET 2: 124 WASHINGTON STREET, SUITE 101 CITY: FOXBORO STATE: MA ZIP: 02035 BUSINESS PHONE: 617-679-9600 MAIL ADDRESS: STREET 1: C/O VERDOLINO & LOWEY, P.C. STREET 2: 124 WASHINGTON STREET, SUITE 101 CITY: FOXBORO STATE: MA ZIP: 02035 4 1 tm237991-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-02-24 0 0001709401 Rubius Therapeutics, Inc. RUBY 0001874962 Appelhans Dannielle C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON ST. FOXBOROUGH MA 02035 0 1 0 0 CEO and President Common Stock 2023-02-24 4 S 0 10385 0.1274 D 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1273 to $0.1274, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Dannielle Appelhans 2023-02-27